Theremia is an AI-powered platform revolutionizing drug development by optimizing drug derivatives for specific population subgroups, particularly in neurological disorders like Parkinson’s, Alzheimer’s, Depression, and ALS. Leveraging advanced molecular and phenotypic algorithms alongside machine learning techniques, Theremia tailors drug properties—such as dosage, frequency, and formulation—to enhance efficacy and minimize side effects.